Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
RegenXBio (RGNX)
NASDAQ:RGNX
RegenXBio (RGNX) Stock Price & Analysis
421 Followers
RGNX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$18.69 - $35.73
Previous Close$20.13
Volume501.50K
Average Volume (3M)403.49K
Market Cap
$874.92M
Enterprise Value$605.08M
Total Cash (Recent Filing)$364.64M
Total Debt (Recent Filing)$94.80M
Price to Earnings (P/E)-3.1
Beta0.43
Next Earnings
May 09, 2023EPS Estimate
-$1.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.50
Shares Outstanding43,293,631
10 Day Avg. Volume390,434
30 Day Avg. Volume403,491
Standard Deviation0.16
R-Squared0.13
Alpha0.00160
Financial Highlights & Ratios
Price to Book (P/B)1.70
Price to Sales (P/S)11.80
Price to Cash Flow (P/CF)5.70
P/FCF Ratio-5.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.37
Enterprise Value/Gross Profit10.40
Enterprise Value/Ebitda-2.48
Forecast
1Y Price Target
$43.78Price Target Upside109.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
RegenXBio News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RGNX FAQ
What was RegenXBio’s price range in the past 12 months?
RegenXBio lowest stock price was $18.69 and its highest was $35.73 in the past 12 months.
What is RegenXBio’s market cap?
Currently, no data Available
When is RegenXBio’s upcoming earnings report date?
RegenXBio’s upcoming earnings report date is May 09, 2023 which is in 49 days.
How were RegenXBio’s earnings last quarter?
RegenXBio released its earnings results on Feb 28, 2023. The company reported -$1.38 earnings per share for the quarter, missing the consensus estimate of -$1.283 by -$0.097.
Is RegenXBio overvalued?
According to Wall Street analysts RegenXBio’s price is currently Undervalued.
Does RegenXBio pay dividends?
RegenXBio does not currently pay dividends.
What is RegenXBio’s EPS estimate?
RegenXBio’s EPS estimate is -$1.42.
How many shares outstanding does RegenXBio have?
RegenXBio has 43,463,654 shares outstanding.
What happened to RegenXBio’s price movement after its last earnings report?
RegenXBio reported an EPS of -$1.38 in its last earnings report, missing expectations of -$1.283. Following the earnings report the stock price went up 8.494%.
Which hedge fund is a major shareholder of RegenXBio?
Among the largest hedge funds holding RegenXBio’s share is Woodline Partners LP. It holds RegenXBio’s shares valued at 12M.
---
RegenXBio Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$43.78 (109.67% Upside)
$43.78 (109.67% Upside)
Blogger Sentiment
Bullish
RGNX Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 572.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.88%
12-Months-Change
Fundamentals
Return on Equity
-43.78%
Trailing 12-Months
Asset Growth
-25.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
RegenXBio
REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
---
---